We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Donating Dantrolene: Development and Implementation of a Malignant Hyperthermia Program in a Scarce Resource Setting.
- Authors
Smith, Alyssa
- Abstract
Intravenous dantrolene is the first-line treatment of malignant hyperthermia (MH), however, it is not always accessible in lower-middle income countries (LMICs). Facilities in the United States are in a transition period where dantrolene is being replaced with Ryanodex, therefore, there is an opportunity for excess dantrolene to be utilized in LMICs where neither dantrolene nor Ryanodex exist. Thirty-six vials of recently expired, unused dantrolene were obtained for a hospital in a LMIC and an MH program was developed in conjunction with the Lao Friends Hospital for Children (LFHC) anesthesia providers, LFHC liaison, LFHC leadership team, and an expert in the field of MH. Components of the MH program included developing a facilityspecific protocol, treatment guidelines, supply list, and educational tools. A designated MH drawer was also created in preparation for an MH event. By procuring dantrolene and implementing an MH program in a facility where no MH protocol, treatment guidelines, supply list, or educational tools existed, LFHC is better equipped to handle a potentially lethal scenario.
- Subjects
DANTROLENE; HEALTH education; INTRAVENOUS therapy; MIDDLE-income countries; WORLD health; MALIGNANT hyperthermia; MEDICAL protocols; HUMAN services programs; OPERATING room technicians; LOW-income countries; DRUG storage; PHARMACODYNAMICS
- Publication
AANA Journal, 2022, Vol 90, Issue 4, p271
- ISSN
0094-6354
- Publication type
Article